In Australia, over 200,000 people live with epilepsy, a chronic neurological condition that is often characterised by seizures. Thousands are…
Since the easing of regulatory red tape and wider societal acceptance of utilising cannabis for its medical properties, the medicinal…
Are investors panic selling their shares at medicinal cannabis company Cronos Australia (ASX: CAU)? With 73.4% of the Company’s shares…
Cannabis is having a major moment these past few years, trending in research and trickling down into the retail sector. …
Putting behind them the drama of 2021 which resulted in their former Chairman’s offices being raided by Australian Federal Police,…
With rising COVID cases around the world following the latest Omicron strain outbreak, UK regulators are willing to try anything…